Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

STUDY: American Heart Association Journal Finds mRNA COVID-19 Jabs Dramatically Increase Cardiac Inflammation And Other Vascular Events


A recent abstract published by a scientific journal from the American Heart Association obliterates the narrative of the “safe and effective” mRNA COVID-19 injections.

Here’s why this newly released information is paramount and cannot be ignored by medical tyrants pushing this medical experiment on the global population.

Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning was published on November 8th, 2021 in Circulation.

What’s Circulation?

Here’s a quick rundown from Wikipedia:

Circulation is a scientific journal published by Lippincott Williams & Wilkins for the American Heart Association. The journal publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research. Its 2019 impact factor is 23.603, ranking it first among journals in the Cardiac and Cardiovascular Systems category. [3] Articles become open access after a 12-month embargo period.

Circulation is divided into subspecialty journals and Abstract 10712 was published in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).

A definition of the journal from Wikipedia:

Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott Williams & Wilkins, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.

The journal was established in 1981 as Arteriosclerosis (ISSN 0276-5047), which was published bimonthly. From 1991 to 1994 it was published monthly under the title Arteriosclerosis and Thrombosis: A Journal of Vascular Biology (ISSN 1049-8834).[1]

According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.311,[2] ranking it 8th in the category “Hematology”[2] and 5th in the category “Peripheral Vascular Disease”.[2] Alan Daugherty has been the editor-in-chief since 2012.[3]

ATVB is a highly-respected, peer-reviewed medical journal that publishes bi-monthly editions.

Healthcare professionals cannot dismiss the research displayed in the journal.

And the findings from Abstract 10712 relay horrific information about catastrophic cardiovascular damage following the mRNA COVID-19 injections.

Here’s a snapshot in case of censorship:

I’ve included the entire text from Abstract 10712 directly from and highlighted important details:

Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score. The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients. This report summarizes those results. A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac. These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac. We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.

Save this journal publication whenever someone tells you to “follow the science” on the mRNA COVID-19 injections.

Is this the science they follow?


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!